论文部分内容阅读
目的:评价用液基细胞学检测系统(TCT)联合HPV-DNA检测对宫颈病变的诊断价值。方法:用TCT和HPV-DNA检测与病理学诊断的符合率,并观察TCT基础上对ASC进行HPV-DNA检测,观察联合检测是否提高与病理的符合率。结果:TCT检测和HPV-DNA检测与病理的符合率分别为87.0%和72.0%,在TCT基础上对ASC进行HPV-DNA检测,发现联合检测与病理检测的符合率高达92.0%。结论:TCT和HPV检测能够提高检出敏感度和高度病变的阳性符合率,在宫颈癌和癌前病变筛查中可以用TCT或HPV检测提高检出率。
Objective: To evaluate the diagnostic value of TCT combined with HPV-DNA in diagnosis of cervical lesions. Methods: The coincidence rates of TCT and HPV-DNA in pathological diagnosis were detected. The HPV-DNA of ASC was observed on the basis of TCT. The coincidence rate of combined detection and pathology was observed. Results: The coincidence rates of TCT test, HPV-DNA test and pathology were 87.0% and 72.0% respectively. HPV-DNA was detected on the basis of TCT. The coincidence rate of combined detection and pathological examination was 92.0%. CONCLUSION: TCT and HPV tests can increase the positive coincidence rate of detection sensitivity and high degree of disease. Detection rate of TCT or HPV in cervical cancer and precancerous lesions screening can be increased.